BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mamori S, Asakura T, Ohkawa K, Tajiri H. Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. World J Gastroenterol 2007; 13(40): 5306-5311 [PMID: 17879398 DOI: 10.3748/wjg.v13.i40.5306]
URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5306.htm
Number Citing Articles
1
Han Shen, Hong-Wei Shao, Xiao-Hua Chen, Feng-Lin Wu, Hui Wang, Zhao-Liang Huang, Juan Shen, Teng Wang, Wen-Feng Zhang, Shu-Lin Huang. Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigenCancer Immunology, Immunotherapy 2013; 62(2): 393 doi: 10.1007/s00262-012-1323-4
2
Zhi-Bo Xie, Liang Ma, Xiao-Bo Wang, Tao Bai, Jia-Zhou Ye, Jian-Hong Zhong, Le-Qun Li. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic reviewTumor Biology 2014; 35(9): 8451 doi: 10.1007/s13277-014-2340-z
3
Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodriguez-Carnero, Raquel Perez-Lois, Luisa M. Seoane, Felipe F. Casanueva, Ana B. Crujeiras. Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory DiseaseInternational Journal of Molecular Sciences 2022; 23(23): 15002 doi: 10.3390/ijms232315002
4
Michaela Muth, Katharina Theophile, Kais Hussein, Christoph Jacobi, Hans Kreipe, Oliver Bock. "Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression"Journal of Translational Medicine 2010; 8(1) doi: 10.1186/1479-5876-8-33
5
Jin Wang, Wei Li. Discovery of Novel Second Mitochondria-Derived Activator of Caspase Mimetics as Selective Inhibitor of Apoptosis Protein InhibitorsJournal of Pharmacology and Experimental Therapeutics 2014; 349(2): 319 doi: 10.1124/jpet.113.212019
6
Katerina Malagari, Mary Pomoni, Alexis Kelekis, Anastasia Pomoni, Spyros Dourakis, Themis Spyridopoulos, Hippokratis Moschouris, Emmanouil Emmanouil, Spyros Rizos, Dimitrios Kelekis. Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular CarcinomaCardioVascular and Interventional Radiology 2010; 33(3): 541 doi: 10.1007/s00270-009-9750-0
7
Eiman Adel Hasby, Mohammed Alaa Mokhtar. Survivin immunohistochemical expression in hepatocellular carcinoma: Correlation with tumour differentiation and proliferationArab Journal of Gastroenterology 2010; 11(3): 141 doi: 10.1016/j.ajg.2010.07.001
8
Robert Martin, Javier Irurzun, Jordi Munchart, Igor Trofimov, Alexander Scupchenko, Cliff Tatum, Govindarajan Narayanan. Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and doseThe Korean Journal of Hepatology 2011; 17(1): 51 doi: 10.3350/kjhep.2011.17.1.51
9
Hong-bo WEI, Bao-guang HU, Xiao-yan HAN, Zong-heng ZHENG, Bo WEI, Jiang-long HUANG. Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cellsChinese Medical Journal 2008; 121(4): 331 doi: 10.1097/00029330-200802020-00010
10
Xiangxuan Zhao, Olorunseun O. Ogunwobi, Chen Liu, Carlo Gaetano. Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma CellsPLoS ONE 2011; 6(8): e21980 doi: 10.1371/journal.pone.0021980
11
Guido Bonomo, Vittorio Pedicini, Lorenzo Monfardini, Paolo Della Vigna, Dario Poretti, Gianluigi Orgera, Franco Orsi. Bland Embolization in Patients with Unresectable Hepatocellular Carcinoma Using Precise, Tightly Size-Calibrated, Anti-Inflammatory Microparticles: First Clinical Experience and One-Year Follow-UpCardioVascular and Interventional Radiology 2010; 33(3): 552 doi: 10.1007/s00270-009-9752-y
12
Jagat R. Kanwar, Sishir K. Kamalapuram, Rupinder K. Kanwar. Targeting survivin in cancer: the cell-signalling perspectiveDrug Discovery Today 2011; 16(11-12): 485 doi: 10.1016/j.drudis.2011.04.001